尚太科技(001301.SZ):2023年度擬向銀行、融資租賃公司等金融機構申請不超30億元綜合授信額度
格隆匯1月11日丨尚太科技(001301.SZ)公佈,由於公司業務規模增長,進一步擴充產能,預計公司資金需求量將大幅增加,為滿足公司發展需要及日常經營資金需求,降低融資成本,提高資金使用效率,公司及子公司2023年度擬向銀行、融資租賃公司等金融機構申請總額不超過人民幣30億元綜合授信額度,用於辦理包括但不限於貿易融資(信用證)授信、流動資金(貸款)授信、銀承授信額度、非融資性保函、交易對手風險額度(一年期以內的遠期結售匯)、項目固貸、保理、信保項下出口融資、設備固貸、融資租賃等中長期貸款和綜合授信業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.